Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NimbusRF appears to have been a small medical device business focused on radiofrequency ablation technology for interventional pain management rather than a drug-development biotech company. Its flagship product was the Nimbus Electrosurgical Radiofrequency Multitined Expandable Electrode, an FDA-cleared device intended for radiofrequency heat lesion procedures for relief of pain. The business was originally associated with Biomerics in Salt Lake City, Utah, and in January 2020 its assets were acquired by newly formed Stratus Medical to support commercialization and expansion of the Nimbus RF product line. Today, Nimbus is marketed under Stratus Medical rather than as an independent operating company. Because NimbusRF was a device business, most biopharma-specific fields such as molecular targets, therapeutic pipeline, and clinical modalities are not applicable.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NimbusRF.